Clincosm LogoSign in Get a demo

Carcinoma, Renal Cell

Showing NaN - NaN of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Carcinoma, Renal Cell Trial in Worldwide (Atezolizumab, Cabozantinib)

Active, not recruiting
  • Carcinoma, Renal Cell
  • Tucson, Arizona
  • +147 more
Jan 24, 2023

Carcinoma, Renal Cell Trial in Worldwide (tivozanib HCl, Sorafenib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Phoenix, Arizona
  • +190 more
Jan 18, 2022

Carcinoma, Renal Cell Trial in Worldwide (Pazopanib, Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Huntsville, Alabama
  • +226 more
Apr 19, 2021

Carcinoma, Renal Cell Trial in Philadelphia (Pazopanib, DCE-MRI and Quantitative Doppler Ultrasound)

Completed
  • Carcinoma, Renal Cell
  • Pazopanib
  • DCE-MRI and Quantitative Doppler Ultrasound
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Mar 25, 2020

Carcinoma, Renal Cell, Kidney Diseases, Kidney Tumors Trial in United States (Combination of varlilumab and sunitinib)

Terminated
  • Carcinoma, Renal Cell
  • +8 more
  • Combination of varlilumab and sunitinib
  • Birmingham, Alabama
  • +8 more
Jul 24, 2018

Carcinoma, Renal Cell Trial in United States (foretinib (formerly GSK1363089 or XL880))

Completed
Has Results
  • Carcinoma, Renal Cell
  • foretinib (formerly GSK1363089 or XL880)
  • Greenbrae, California
  • +11 more
Nov 8, 2017

Carcinoma, Renal Cell Trial in Australia, United States (GW786034)

Completed
  • Carcinoma, Renal Cell
  • Little Rock, Arkansas
  • +7 more
Jan 16, 2017

Carcinoma, Renal Cell Trial in United Kingdom, United States (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Chicago, Illinois
  • +6 more
Dec 18, 2014

Carcinoma, Renal Cell Trial in Canada, United States (Sorafenib (Nexavar, BAY43-9006))

Completed
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Bessemer, Alabama
  • +319 more
Aug 5, 2014

Carcinoma, Renal Cell Trial in Worldwide (Sorafenib (Nexavar, BAY43-9006), Placebo)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sorafenib (Nexavar, BAY43-9006)
  • Placebo
  • Tucson, Arizona
  • +120 more
Jan 8, 2014

Carcinoma, Renal Cell, Kidney Tumors Trial in Worldwide (Interferon Alfa, CCI-779, Interferon Alfa and CCI-779)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Interferon Alfa
  • +2 more
  • Little Rock, Arkansas
  • +153 more
Sep 24, 2012

Kidney Tumors, Carcinoma, Renal Cell Trial in United States (AG-013736 (axitinib))

Completed
Has Results
  • Kidney Neoplasms
  • Carcinoma, Renal Cell
  • AG-013736 (axitinib)
  • Chicago, Illinois
  • +4 more
Jul 23, 2012

Carcinoma, Renal Cell Trial in United States (Sunitinib Malate Continuous Daily Dosing, Sunitinib Malate Schedule 4/2)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Sunitinib Malate Continuous Daily Dosing
  • Sunitinib Malate Schedule 4/2
  • Hot Springs, Arkansas
  • +158 more
Aug 3, 2011

Carcinoma, Renal Cell Trial in Ann Arbor, New York, Philadelphia (Gefitinib + Sunitinib)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Gefitinib + Sunitinib
  • Ann Arbor, Michigan
  • +2 more
Aug 25, 2011

Carcinoma, Renal Cell, Kidney Tumors Trial in United States (ZD6126, Placebo)

Suspended
  • Carcinoma, Renal Cell
  • Kidney Neoplasms
  • Los Angeles, California
  • +15 more
Jan 25, 2011

Carcinoma, Renal Cell Trial in United States (SU011248)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Duarte, California
  • +14 more
Oct 8, 2010

Carcinoma, Renal Cell Trial in Worldwide (Interferon-alfa, SU011248)

Completed
Has Results
  • Carcinoma, Renal Cell
  • Jonesboro, Arkansas
  • +123 more
Jan 19, 2010

Carcinoma, Renal Cell, Metastases, Tumor Trial in United States (GTI-2040)

Completed
  • Carcinoma, Renal Cell
  • Metastases, Neoplasm
  • Concord, California
  • +9 more
Jan 4, 2008